Investigational Product - MIB 626

DRUG2 trials

Sponsors

Brigham and Women's Hospital, Metro International Biotech, LLC

Conditions

Diabetic Kidney DiseaseHealthyType2diabetes

Phase 2

NAD Augmentation in Diabetes Kidney Disease

RecruitingNCT05759468

Brigham and Women's HospitalDiabetic Kidney Disease, Type2diabetes

Start: 2023-04-13End: 2027-03-31Target: 156Updated: 2026-04-13

Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program

CompletedNCT05878119

Metro International Biotech, LLCHealthy

Start: 2023-10-25End: 2025-08-04Updated: 2026-01-21